Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The study medication was injected once weekly for 40 weeks
A provider needs to review medical history, current medications, and goals before recommending semaglutide, tirzepatide, or a supportive addition like B12 or NAD
Patients should have regular consultations with their healthcare provider to monitor response and adjust dosing as appropriate
Retatrutide carries a research use only designation and is not approved for human consumption or clinical treatment
To further reduce contamination risks, aliquot the reconstituted solution into sterile microtubes and label each one with the contents, concentration, and reconstitution date
GLP-1 Receptor Agonist Market Share Companies such as Novo Nordisk, Eli Lilly, AstraZeneca, and Sanofi dominate this market due to their strong research capabilities, innovative drug formulations, and commitment to addressing diabetes and obesity challenges
US$ 29.08
US$ 28.75
US$ 26.70
US$ 28.67
US$ 24.58
US$ 25.19
US$ 20.44
US$ 22.69
US$ 26.08
